News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

Revlimid (lenolidamide) Idenix (IDIX) ImmunoGen (IMGN) ZALTRAP™ Genentech AERIE PHARMACEUTICALS Ridaforolimus Galena (GALE) Intrexon (XON) ISIS (ISIS) Elan (ELN) Array Pharmaceuticals (ARRY) PORTOLA (PTLA) Sanofi (SNY) Ionis (IONS) Benlysta (belimumab) Anacor (ANAC) Alder Biopharmaceuticals (ALDR) Sarepta (SRPT) Alnylam (ALNY) CRISPR Therapeutics (CRSP) Editas (EDIT) TOKAI (TKAOI) Incyte (INCY) Endometrial Cancer Gilead (GILD) ARGOS (ARGS) HALOZYME (HALO) Vertex (VRTX) GlaxoSmithKline (GSK) Xoma (XOMA) Agenus (AGEN) Biogen Idec (BIIB) Illumina (ILMN) MODERNA CompuGen (CGEN) Human Genome Sciences (HGSI) Multiple Myeloma Theravance (THRX) Adaptimmune (ADAP) Regeneron (REGN) Telaprevir AstraZeneca (AZN) Rapamune Biocryst (BCRX) IDERA (IDRA) Velcade (bortezomib) Aimmune Therapeutics (AIMT) Agenus (AGEN NEKTAR (NKTR)) PTC Therapeutics (PTCT) RenenxBio (RGNX) INNOVIVA (INVA) Anadys (ANDS) Roche (RHHBY) Exelixis (EXEL) BIOMARIN (BMRN) ABBVIE (ABBV) SUNESIS PHARMACEUTICALS (SNSS) Roche (ROCHE) Dendreon (DNDN) Merck (MRK) Vitae Pharmaceuticals (VTAE) KITE (KITE) Theravance Bio Pharma (TBPH) NOVOCURE (NVCR) Dynavax (DVAX) Bellicum (BLCM) Auspex (ASPX) Intermune (ITMN) REGULUS (RGLS) Amgen (AMGN) Herceptin VANDA (VNDA) Trastuzumab-DM1 Advaxis (ADXS) SYNTA (SNTA) AGOS (ARGS) KERYX (KERX) Human Longevity (HLI) Ariad (ARIA) Valeant Pharmaceuticals International (VRX) Global Cell Therapeutics (GBT) Intercept (ICPT) Ocular Therapeutix (OCUL) GUARDIAN HEALTH CEMPRA (CEMP) JUNO (JUNO) Bristol-Myers Squibb (BMY) Zerenex Spike Therapeutics (ONCE) Pluristem (PSTI) Micromet (MITI) Cytokinetics (CYTK) Abbott Laboratories (ABT) OSI (OSIP) Inovio (INO) galapagos (GLPG) Seattle Genetics (SGEN) ADVENTRIX (ANX) Sanofi-Aventis (SAN) Prolor Biotech (PBTH) NANTKWEST (NK) Jazz Pharmaceuticals (JAZZ) Prosensa (RNA) Tysabri Sangamo (SGMO) Onyx (ONXX) Sequenom (SQNM) C4 Therapeutics Mirati Therapeutics (MRTX) SERES THERAPEUTICS (MCRB) ARCA (ABIO) Sanofi (SNA) ACADIA (ACAD) Ziofpharm (ZIOP)